6.
Borra R, Salo S, Dean K, Lautamaki R, Nuutila P, Komu M
. Nonalcoholic fatty liver disease: rapid evaluation of liver fat content with in-phase and out-of-phase MR imaging. Radiology. 2008; 250(1):130-6.
DOI: 10.1148/radiol.2501071934.
View
7.
Guiu B, Petit J, Loffroy R, Ben Salem D, Aho S, Masson D
. Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy. Radiology. 2008; 250(1):95-102.
DOI: 10.1148/radiol.2493080217.
View
8.
Cassidy F, Yokoo T, Aganovic L, Hanna R, Bydder M, Middleton M
. Fatty liver disease: MR imaging techniques for the detection and quantification of liver steatosis. Radiographics. 2009; 29(1):231-60.
DOI: 10.1148/rg.291075123.
View
9.
Yokoo T, Bydder M, Hamilton G, Middleton M, Gamst A, Wolfson T
. Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology. 2009; 251(1):67-76.
PMC: 2663579.
DOI: 10.1148/radiol.2511080666.
View
10.
Schwenzer N, Springer F, Schraml C, Stefan N, Machann J, Schick F
. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol. 2009; 51(3):433-45.
DOI: 10.1016/j.jhep.2009.05.023.
View
11.
Mennesson N, Dumortier J, Hervieu V, Milot L, Guillaud O, Scoazec J
. Liver steatosis quantification using magnetic resonance imaging: a prospective comparative study with liver biopsy. J Comput Assist Tomogr. 2009; 33(5):672-7.
DOI: 10.1097/RCT.0b013e318199d883.
View
12.
Angulo P
. Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance?. Hepatology. 2010; 51(2):373-5.
PMC: 2945376.
DOI: 10.1002/hep.23521.
View
13.
van Werven J, Marsman H, Nederveen A, Smits N, Ten Kate F, van Gulik T
. Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy. Radiology. 2010; 256(1):159-68.
DOI: 10.1148/radiol.10091790.
View
14.
Meisamy S, Hines C, Hamilton G, Sirlin C, McKenzie C, Yu H
. Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology. 2011; 258(3):767-75.
PMC: 3042638.
DOI: 10.1148/radiol.10100708.
View
15.
Vernon G, Baranova A, Younossi Z
. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011; 34(3):274-85.
DOI: 10.1111/j.1365-2036.2011.04724.x.
View
16.
Hansen K, Schroeder M, Hamilton G, Sirlin C, Bydder M
. Robustness of fat quantification using chemical shift imaging. Magn Reson Imaging. 2011; 30(2):151-7.
PMC: 3254829.
DOI: 10.1016/j.mri.2011.09.011.
View
17.
Kuhn J, Hernando D, Rio A, Evert M, Kannengiesser S, Volzke H
. Effect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging results. Radiology. 2012; 265(1):133-42.
PMC: 3447175.
DOI: 10.1148/radiol.12112520.
View
18.
Hwang I, Lee J, Lee K, Yoon J, Kiefer B, Han J
. Hepatic steatosis in living liver donor candidates: preoperative assessment by using breath-hold triple-echo MR imaging and 1H MR spectroscopy. Radiology. 2014; 271(3):730-8.
DOI: 10.1148/radiol.14130863.
View
19.
Karlas T, Petroff D, Garnov N, Bohm S, Tenckhoff H, Wittekind C
. Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy. PLoS One. 2014; 9(3):e91987.
PMC: 3956815.
DOI: 10.1371/journal.pone.0091987.
View
20.
Lee S, Park S
. Radiologic evaluation of nonalcoholic fatty liver disease. World J Gastroenterol. 2014; 20(23):7392-402.
PMC: 4064084.
DOI: 10.3748/wjg.v20.i23.7392.
View